Evidence map›Paper›PMID 42844296›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2026

Concept of organ dysfunction revealed by shift in thinking from V = IR to W = VI.

Masaki Mogi, Shuang Liu, Yasuyuki Suzuki, Satoshi Hoshide, Kazuomi Kario

Abstract readEditorial
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Masaki MogiDepartment of Pharmacology, Ehime University Graduate School of Medicine, Toon, Japan. mmogi@m.ehime-u.ac.jp.
Shuang LiuDepartment of Pharmacology, Ehime University Graduate School of Medicine, Toon, Japan.
Yasuyuki SuzukiDepartment of Pharmacology, Ehime University Graduate School of Medicine, Toon, Japan.
Satoshi HoshideDivision of Cardiovascular Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.
Kazuomi KarioDivision of Cardiovascular Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blood pressure is expressed as V (blood pressure) = I (circulating blood volume or cardiac output) × R (peripheral vascular resistance), based on Ohm's law (V (voltage) = I (current) × R (resistance)). Antihypertensive drugs that reduce either I or R are used. On the other hand, the electrical energy consumed per unit time is power (W), which is expressed as W = VI. If we consider the energy consumed by each organ to be W, and assume that an organ consumes a constant amount of functional bioenergy requirement (FBR), then V and I work in a complementary manner. It is conceivable that if a decrease in blood flow occurs first due to conditions such as arteriosclerosis or peripheral circulatory failure, peripheral blood pressure will rise compensatorily; conversely, if systemic blood pressure rises first, tissue blood flow will decrease compensatorily, potentially leading to chronic ischemia. In this medical hypothesis, I would like to consider a shift in perspective from V = IR to W = VI in blood pressure management-a field that has traditionally focused on peripheral vascular resistance (R)-by shifting the focus to blood pressure regulation aimed at maintaining FBR in tissues. Conventional blood pressure regulation is based on Ohm's law (V = IR), where antihypertensive therapy primarily targets cardiac output (I) or peripheral vascular resistance (R) to reduce blood pressure. We propose a complementary framework based on W = VI, in which blood pressure (V) and tissue perfusion (I) are regulated cooperatively to preserve the functional bioenergy requirement (FBR) of tissues. Reduced tissue perfusion may induce a compensatory blood pressure elevation, whereas primary blood pressure elevation may trigger autoregulatory responses that limit the pressure-driven increase in tissue blood flow, potentially resulting in chronic tissue ischemia. This paradigm highlights a shift from lowering visible blood pressure alone toward preserving the invisible FBR of tissues. This figure was created with the assistance of generative AI (GPT-5.6 Thinking) based on the content of this paper. The authors have verified the content.

Indexed as

Functional bioenergy requirementIschemiaMedical hypothesisSystemic blood pressureTissue blood flow

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.